NCT02147691

Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 22 (actual)
• Sponsor: Derm Research, PLLC · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

The pilot study will investigate whether combination treatment of Finacea 15% Gel and Brimonidine 0.33% Gel could be more effective than Brimonidine 0.33% Gel monotherapy in treating both the papules/pustules and erythema associated with rosacea.

Detailed description

Acne rosacea is a chronic inflammatory disease with different components including inflammatory lesions (papules/pustules), erythema and telangiectasia. Brimonidine 0.33% Gel primarily affects the erythematous components of rosacea. As such, combination treatment with a standard rosacea treatment, such as Finacea 15% Gel, may provide additional relief for the inflammatory component of rosacea.

Conditions

• Acne Rosacea

Interventions

Type	Name	Description
DRUG	Azelaic acid 15%	Applied to the face each AM and PM
DRUG	Brimonidine 0.33%	Applied to the face each AM 30 minutes after the application of Azelaic acid 15%

Timeline

• Start date: 2014-05-01
• Primary completion: 2015-01-01
• Completion: 2015-02-01
• First posted: 2014-05-28
• Last updated: 2015-09-30
• Results posted: 2015-09-30

Locations

1 site across 1 country: United States